The first, an investigational norovirus mRNA vaccine from Moderna (mRNA-1403), safely elicited strong antibody responses in adults against globally prevalent norovirus genotypes, according to interim results of a phase I/II clinical trial. The trivalent vaccine uses the same technology as the company's COVID and RSV shots.

It is hoped the new norovirus jab could help lift the burden on the NHS over the busy winter months - here we explain who is eligible for the trial, and when will everyone be able to get it

A new vaccine that could stop people from developing the vomiting bug norovirus is on trial in the UK. The mRNA vaccine from Moderna will enter the final stages of testing within the next two weeks, according to health officials,

The most recent figures in the Weekly Surveillance Report for England show activity during weeks 40 to 41 of 2024 as 43% higher than the 5-season average for the same 2-week period. The monthly report covers the 2-week period between September, 30 to October 13 reporting week 41 of the 2024/2025 season.

The winter vomiting bug affects millions of Britons every year, but a new vaccine could help reduce the massive impact of norovirus.

A world-first vaccine for the vomiting bug norovirus is being trialled in the UK, with the hope it could cut the "burden" on the National Health Service (NHS), the UK health secretary has said.The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks,

A vaccine for the vomiting bug norovirus is being trialled in the UK for the first time, with the hope it could cut the “burden on the NHS”, the Health Secretary has said. The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks,

A first-of-its-kind vaccine against the vomit bug norovirus is being trialled in the UK, using the same tech employed in the Covid jab. Thousands of Brits end up in hospital every year due to the highly contagious virus,